4D Molecular Therapeutics, Inc. (FDMT) Capital expenditures 2019–2025
4D Molecular Therapeutics, Inc. (FDMT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$536,000FY2025 · since FY2019: $3.2M → $536,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $536,000 | -85.8% |
| FY2024 | $3.8M | +36.6% |
| FY2023 | $2.8M | -76.0% |
| FY2022 | $11.5M | +26.6% |
| FY2021 | $9.1M | +811.0% |
| FY2020 | $1.0M | -68.8% |
| FY2019 | $3.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice